2364. Surprising Prescribing: Treatment Practices following Addition of Toxin Testing to an Existing Molecular Test for Clostridioides difficile

類似資料

• Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients
  著者:: Miller, Ryan, 等
  出版事項: (2020)
• 2379. It’s Getting Complicated: Outcomes of Clostridiodes difficile PCR Positive/Toxin-Negative Patients
  著者:: Morillas, Jose A, 等
  出版事項: (2019)
• 2373. Impact of a Change in Testing Strategy for Clostridioides difficile Infection on a Publicly Reported Metric and Treatment Days of Therapy
  著者:: Miller, Ryan, 等
  出版事項: (2019)
• Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy
  著者:: Sandlund, Johanna, 等
  出版事項: (2020)
• 839. Effect of Clostridioides difficile (C. difficile) Toxin Test Reporting on Clinical Treatment and Outcomes of Toxin-Negative PCR-Positive Patients at Five California Hospitals
  著者:: Polage, Christopher R, 等
  出版事項: (2019)